Adaptimmune Therapeutics Plc (ADAP) — Cash Flow Reinvestment Rate
Adaptimmune Therapeutics Plc (ADAP) has a Cash Flow Reinvestment Rate of 0.03x as of June 2024, reinvesting $1.50 Million (capex $754.55K plus investments $-743.00K) from operating cash flow of $47.39 Million. Explore ADAP capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Adaptimmune Therapeutics Plc Cash Flow Reinvestment Rate (2013–2021)
Historical reinvestment intensity for Adaptimmune Therapeutics Plc across 2 annual periods. Also explore Adaptimmune Therapeutics Plc asset portfolio for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Adaptimmune Therapeutics Plc (2013–2021)
Year-by-year capital reinvestment analysis for Adaptimmune Therapeutics Plc. For live market cap and broader valuation context, see market value of Adaptimmune Therapeutics Plc.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2021 | 8.70x | $93.36 Million | $10.73 Million | $8.78 Million | ▲ +485.6% |
| 2013 | 1.49x | $55.33 Million | $37.23 Million | $1.45 Million | — |